Study year, Reference Country Mean Follow-up time (Month) Plate response (%) Prevalence (%) of H. pyloriinfection
Gasbarrini et al. [10] Italy 4 8/8 (100) 11/18 (61)
Emilia et al. [11] Italy 8.3 6/12 (50) 13/30 (43)
Jarque et al. [18] Spain 24 3/23 (13) 40/56 (71)
Kohda et al. [17] Japan 148 12/19 ( 63) 22/35 (62)
veneri et al. [32] Italy 11.7 11/15 (73) 25/35 (71)
Michel et al. [19] USA 11.5 4/14 (29) 16/74 (22)
Suzuki et al. [12] Japan 6 6/13 (46) 25/36 (69)
Fujimura et al. [14] Japan 12< 88/161 (55) 300/435 (69)
Suvaidzic et al. [37] Serbia 18 6/23 (26) 39/54 (72)
Sayan et al. [38] Turkey 13 8/20 (40) 34/20 (59)
Campuzano-Maya et al. [20] Colombia 12.2 24/29 (83) 29/32 (91)
Estrada-Gomez et al. [39] Mexico 4.6 3/14(21) 14/23 (60)
Sivapathasingam et al. [40] Australia 12.2 5/9 (56) 9/16 (56)
Joakson et al. [41] Canada 48 3/4 (75) 4/22 (18)
Tag et al. [42] Korea 57.6 25/17 (68) 23/25 (92)
Payandeh et al. [43] Iran 6 26/15 (58) 35/52 (67)
Gan et al. [44] Malaysia 6 3/10 (30) 11/50 (22)
Table 1: Platelet response to H. pylori eradication therapy in ITP patients.